Company news
Sichuan Hebang Biotechnology Co. Ltd. news in 2025
Sichuan Hebang Biotechnology Co. Ltd.'s news releases, calls and decks from 2025, newest first.
Announcement on Convening the Q3 2025 Performance Briefing
December 5, 2025
Announcement on Main Operating Data from January to September 2025
October 28, 2025
Announcement on Interest Payment for "Hebang Convertible Bonds"
October 20, 2025
Announcement on Convening the 2025 Semi-annual Performance Briefing
September 11, 2025
Announcement on Completion of Pre-registration for Foreign Investment Projects
September 3, 2025
2025 Semi-annual Report
August 19, 2025
Announcement on Follow-up Rating Results of Convertible Corporate Bonds in 2025
July 28, 2025
Announcement on Completion and Termination of Stock Sales under the Phase III Employee Stock Ownership Plan
July 24, 2025
Announcement on Obtaining Government Subsidies
July 18, 2025
Announcement on SSE’s Reply to "Letter of Supervision and Inquiry on Information Disclosure of 2024 Annual Report of Sichuan Hebang Biotechnology Co., Ltd." (Exemption Version)
July 8, 2025
Announcement on Change in Holding Ratio of Convertible Bonds by Controlling Shareholder Reaching 10%
June 27, 2025
Announcement on Convening the 2024 Annual and Q1 2025 Performance Briefing
June 17, 2025
Indicative Announcement on Changes in the Holding Ratio of Convertible Bonds by Controlling Shareholder and Equity Change Reaching an Integer Multiple of 1%
May 30, 2025
Announcement on Resolution of the 2024 Annual General Meeting
May 26, 2025
Announcement on Using Self-owned Funds, Foreign Exchange, Letter of Credit, Bank Acceptance Bill and Other Means to Pay for Investment Projects Financed by Raised Funds and Replacing with Equivalent Amount of Raised Funds
April 28, 2025
Announcement on the Commencement of Share Conversion of "Hebang Convertible Bonds"
April 25, 2025
Announcement on Resolution of the 1st Extraordinary General Meeting in 2025
March 6, 2025
Announcement on Release of Some Shares of the Controlling Shareholder
February 25, 2025